NCT01941121

Brief Summary

This is a CCTG sponsored project to determine if those recently screened for HIV would accept assistance to be linked into appropriate health services. After receiving their HIV results, high-risk individuals who test negative will have an option to be linked into a study that offers them Pre-exposure Prophylaxis (PrEP), and individuals who test positive will have an option to be linked into care. If they accept, tested individuals will be in contact with an ALERT specialist that will help facilitate their linkage. The study's primary analysis will analyze how many HIV screened individuals accept the ALERT specialist assistance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 26, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 9, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 13, 2013

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 22, 2018

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2021

Completed
Last Updated

May 12, 2021

Status Verified

May 1, 2021

Enrollment Period

4.5 years

First QC Date

September 9, 2013

Last Update Submit

May 10, 2021

Conditions

Keywords

HIV ScreeningLinkage to PrEPLinkage to CareCCTG593

Outcome Measures

Primary Outcomes (1)

  • Proportion of subjects linked to Care or PrEP

    The primary outcome will measure the proportion of subjects linked a) to HIV care within 60 days of testing HIV-positive or b) to PrEP within 90 days of testing HIV-negative

    Up to 60 days for positives and up to 90 days for negatives from date of HIV screening test

Secondary Outcomes (1)

  • Acceptance of the linkage program

    60 days from date of HIV screening test

Study Arms (1)

Linkage to PrEP or Care

EXPERIMENTAL

Subjects screened for HIV at any CCTG consortium site will be offered Linkage to PrEP or Care, depending on HIV status. After results are received, HIV testers will obtain verbal consent from the subject to connect with the ALERT Specialist, or otherwise offer the subject the ALERT Specialist contact information. When contacted, the ALERT Specialist will coordinate with the subject the scheduling of the PrEP or Care visit, and remain in contact to ensure linkage.

Behavioral: Linkage to PrEP or Care

Interventions

Ensuring subjects complete linkage to PrEP or Care through coordinated scheduling and intensive reminders by ALERT Specialist.

Linkage to PrEP or Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Has had an HIV test result form the CCTG Consortium testing site as either positive or negative
  • Ability to provide informed consent
  • English or Spanish Speaking

You may not qualify if:

  • Severe active substance abuse or mental illness that the investigator feels will interfere with the ability to provide informed consent
  • Acute medical illness that requires transfer to a non CCTG hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

City of Long Beach Department of Health and Human Services

Long Beach, California, 90815, United States

Location

University of Southern California

Los Angeles, California, 90033, United States

Location

University of California, San Diego

San Diego, California, 92103, United States

Location

MeSH Terms

Conditions

HIV Seropositivity

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Kathleen Jacobson, MD

    University of Southern California

    STUDY CHAIR
  • Michael Menchine, MD, MPH

    University of Southern California

    STUDY CHAIR
  • Jill Blumenthal, MD

    UC San Diego AntiViral Research Center (AVRC)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 9, 2013

First Posted

September 13, 2013

Study Start

July 26, 2013

Primary Completion

January 22, 2018

Study Completion

February 9, 2021

Last Updated

May 12, 2021

Record last verified: 2021-05

Locations